Follow
Estee Torok
Estee Torok
Bill and Melinda Gates Foundation
Verified email at gatesfoundation.org - Homepage
Title
Cited by
Cited by
Year
Dexamethasone in hospitalized patients with Covid-19—preliminary report
TRC Group
The New England journal of medicine, 2020
5966*2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
34332021
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England
NG Davies, S Abbott, RC Barnard, CI Jarvis, AJ Kucharski, JD Munday, ...
Science 372 (6538), eabg3055, 2021
16552021
SARS-CoV-2 variants, spike mutations and immune escape
WT Harvey, AM Carabelli, B Jackson, RK Gupta, EC Thomson, ...
Nature Reviews Microbiology 19 (7), 409-424, 2021
12342021
Effect of hydroxychloroquine in hospitalized patients with Covid-19
RECOVERY Collaborative Group
New England Journal of Medicine 383 (21), 2030-2040, 2020
8712020
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
8342021
Tuberculous meningitis: a uniform case definition for use in clinical research
S Marais, G Thwaites, JF Schoeman, ME Török, UK Misra, K Prasad, ...
The Lancet infectious diseases 10 (11), 803-812, 2010
7882010
Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity
E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ...
Cell 184 (1), 64-75. e11, 2021
7592021
The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis
M Caws, G Thwaites, S Dunstan, TR Hawn, N Thi Ngoc Lan, NTT Thuong, ...
PLoS pathogens 4 (3), e1000034, 2008
6042008
Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study
SR Harris, EJP Cartwright, ME Török, MTG Holden, NM Brown, ...
The Lancet infectious diseases 13 (2), 130-136, 2013
6022013
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England
E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ...
Nature 593 (7858), 266-269, 2021
6012021
SARS-CoV-2 evolution during treatment of chronic infection
SA Kemp, DA Collier, RP Datir, IATM Ferreira, S Gayed, A Jahun, ...
Nature 592 (7853), 277-282, 2021
5492021
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng, RP Datir, AC Walls, ...
Nature 593 (7857), 136-141, 2021
4912021
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission
L Rivett, S Sridhar, D Sparkes, M Routledge, NK Jones, S Forrest, ...
elife 9, e58728, 2020
4872020
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
4762021
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
EC Thomson, LE Rosen, JG Shepherd, R Spreafico, A da Silva Filipe, ...
Cell 184 (5), 1171-1187. e20, 2021
3982021
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ...
The Lancet 396 (10259), 1345-1352, 2020
3742020
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis
ME Török, NTB Yen, TTH Chau, NTH Mai, NH Phu, PP Mai, NT Dung, ...
Clinical infectious diseases 52 (11), 1374-1383, 2011
3512011
Taking the right measures to control COVID-19
Y Xiao, ME Torok
The Lancet Infectious Diseases 20 (5), 523-524, 2020
3222020
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study
KA Twohig, T Nyberg, A Zaidi, S Thelwall, MA Sinnathamby, S Aliabadi, ...
The Lancet Infectious Diseases 22 (1), 35-42, 2022
3212022
The system can't perform the operation now. Try again later.
Articles 1–20